| Biological Sciences | 2021-2025 | 712 | SE 7 | 99.24 |
| Cellular and Molecular Neuroscience | Lifetime | 204 | SE 12 | 99.28 |
| Clinical Neurology | Lifetime | 203 | SE 7 | 99.21 |
| Physiology | Lifetime | 82 | SE 5 | 97.62 |
| Clinical Neurology | 2021-2025 | 27 | SE 3 | 99.41 |
| Cellular and Molecular Neuroscience | 2021-2025 | 29 | SE 2 | 97.71 |
| Molecular Biology | 2021-2025 | 869 | SE 9 | 95.20 |
| Medical Physiology | 2021-2025 | 448 | SE 15 | 93.59 |
| Adenosine and Purinergic Signaling | Lifetime | 33 | SE 4 | 99.13 |
| Receptor Mechanisms and Signaling | Lifetime | 120 | SE 9 | 99.54 |
| Neuroscience and Neuropharmacology Research | Lifetime | 356 | SE 13 | 99.50 |
| Parkinson's Disease Mechanisms and Treatments | Lifetime | 198 | SE 5 | 99.31 |
| Neuromodulation and Treatments for Neurological Disorders | Lifetime | 166 | SE 4 | 99.18 |
| Neurotransmitter Receptor Influence on Behavior | Lifetime | 248 | SE 11 | 98.91 |
| Neuropeptides and Animal Physiology | Lifetime | 522 | SE 31 | 98.19 |
| Nerve injury and regeneration | Lifetime | 517 | SE 33 | 96.99 |
| S100 Proteins and Annexins | Lifetime | 422 | SE 18 | 96.03 |
| Genetic Neurodegenerative Diseases | Lifetime | 824 | SE 7 | 95.88 |
| Nuclear Receptors and Signaling | Lifetime | 321 | SE 7 | 95.52 |
| Pharmacological Receptor Mechanisms and Effects | Lifetime | 418 | SE 11 | 94.24 |
| Restless Legs Syndrome Research | Lifetime | 857 | SE 9 | 81.91 |
| Parkinson's Disease Mechanisms and Treatments | 2021-2025 | 26 | SE 1 | 99.43 |
| Neuromodulation and Treatments for Neurological Disorders | 2021-2025 | 32 | SE 1 | 99.10 |
| Neuroscience and Neuropharmacology Research | 2021-2025 | 133 | SE 1 | 96.84 |
| Receptor Mechanisms and Signaling | 2021-2025 | 83 | SE 3 | 95.82 |
| Nuclear Receptors and Signaling | 2021-2025 | 37 | SE 1 | 90.68 |
| Genetic Neurodegenerative Diseases | 2021-2025 | 209 | SE 1 | 92.80 |
| Tryptophan and brain disorders | 2021-2025 | 699 | SE 7 | 89.42 |
| Neurological diseases and metabolism | 2021-2025 | 116 | SE 3 | 89.10 |
| Restless Legs Syndrome Research | 2021-2025 | 68 | SE 2 | 90.22 |
| Lysosomal Storage Disorders Research | 2021-2025 | 252 | SE 1 | 89.23 |
| Botulinum Toxin and Related Neurological Disorders | 2021-2025 | 498 | SE 11 | 85.91 |
| Neuropeptides and Animal Physiology | 2021-2025 | 275 | SE 7 | 85.11 |
| Cellular transport and secretion | 2021-2025 | 348 | SE 2 | 83.42 |
| Stress Responses and Cortisol | 2021-2025 | 830 | SE 9 | 83.90 |
| RNA regulation and disease | 2021-2025 | 442 | SE 3 | 79.18 |
